| abstract |
The present invention, in its many embodiments, comprises a novel class of chroman compounds of formula I as inhibitors of α2C adrenergic receptor agonists, Methods for preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods for preparing pharmaceutical formulations comprising one or more such compounds, and such compounds or pharmaceutical compositions Methods of treating, preventing, inhibiting or alleviating one or more conditions associated with α2C adrenergic receptors using the product are provided. |